10X Genomics Inc expected to post a loss of 36 cents a share - Earnings Preview

10x Genomics

13/02/2024 22:15

* 10X Genomics Inc  TXG.OQ   TXG.O  is expected to show a
rise in
quarterly revenue when it reports  results on February 15 for
the period ending December 31 2023
    * The Pleasanton California-based  company is expected to
report a
17.0% increase in revenue to $182.803 million from $156.23
million a year ago, according to the mean estimate from 14
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for 10X Genomics Inc is for
a loss
of 36 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for 10X
Genomics Inc
is $60.00​, above​ its last closing price of $49.11. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.46       -0.46      -0.79     Missed  -71.9
 Jun. 30 2023  -0.41       -0.40      -0.53     Missed  -31.3
 Mar. 31 2023  -0.35       -0.37      -0.44     Missed  -17.7​
 Dec. 31 2022  -0.30       -0.31      -0.15     Beat    51.9
 ​​Sep.        -0.47       -0.46      -0.37     Beat    20.3
 30 2022                                                
 Jun. 30 2022  -0.40       -0.39      -0.57     Missed  -46.9​
 Mar. 31 2022  -0.33       -0.31      -0.38     Missed  -21.5
 Dec. 31 2021  -0.11       -0.09      -0.16     Missed  -85.2
 This summary was machine generated February 13 at 22:15 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)